SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-092435
Filing Date
2020-08-10
Accepted
2020-08-10 08:30:41
Documents
47
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2020420-1_10q.htm 10-Q 391535
2 EXHIBIT 31.1 tm2020420d1_ex31-1.htm EX-31.1 9936
3 EXHIBIT 31.2 tm2020420d1_ex31-2.htm EX-31.2 9640
4 EXHIBIT 32.1 tm2020420d1_ex32-1.htm EX-32.1 4152
  Complete submission text file 0001104659-20-092435.txt   3119164

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT clrb-20200630.xml EX-101.INS 672494
6 XBRL TAXONOMY EXTENSION SCHEMA clrb-20200630.xsd EX-101.SCH 28966
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clrb-20200630_cal.xml EX-101.CAL 28099
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clrb-20200630_def.xml EX-101.DEF 117702
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clrb-20200630_lab.xml EX-101.LAB 252510
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clrb-20200630_pre.xml EX-101.PRE 223032
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36598 | Film No.: 201087244
SIC: 2834 Pharmaceutical Preparations